ReviewCells2019

Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.

I-Tsu Chyuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.